The company’s Rx Guardian CD medication monitoring now includes oxymorphone, allowing physicians to compare their patients’ levels with a database of patients who were prescribed oxymorphone for chronic pain and were clinically assessed as adherent.
More Articles on Pain Management:
5 Statistics on Chiropractic Use for Medicare Patients
5 Statistics on Anxiety for Pain Patients at EDs
Chronic Pain Management Costs $635B Annually
Ameritox Now Detects Oxymorphone Misuse
Ameritox now offers test enhancements to detect misuse and abuse of oxymorphone, or Opana.
